Amperometric Monitoring of the Neuropeptide “Substance-P” Level in Biological Fluids  by Horak, Josef et al.





Proceedings of the Eurosensors XXIII conference 
Amperometric Monitoring of the Neuropeptide “Substance-P” Level 
in Biological Fluids 
Josef Horak, Barbara Enderle, Hüseyin Bakirci*, Gerald A. Urban 
Department of Microsystems Engineering, Albert-Ludwigs-University Freiburg, Georges-Koehler-Allee 103, 79110 Freiburg, Germany 
 
Abstract 
Presented here is a capillary enzyme immunoassay constructed on a foil-based microfluidic chip for rapid determination of 
Substance-P (SP) level in human plasma, serum and saliva. Using a competitive ELISA implemented into the capillary, the 
amperometrically detected SP by flow injection analysis was related to the percentage amount between SP standard (or sample) 
and SP-labelled glucose oxidase conjugate bound to the capture antibody. A detection limit of 10 pg/ml was obtained. The assay 
allows fast reading of diagnostically relevant levels. Producing reliable results comparable to microplate format, the immunochip 
sensor may have a significant impact in point of care diagnostics.  
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1. Introduction 
The undecapeptide Substance-P known as an important neurotransmitter of the tachykinin family
1 
of 
neuropeptides is a key mediator in pain perception and immune response. Increased SP plasma levels
2-3
 have been 
diagnosed in several cases of pathophysiological disorders, including inflammatory bowel disease, sickle cell crisis, 
depression and anxiety, rheumatological diseases, and infectious diseases such as AIDS, as well as in cancer. High 
variability levels and poor stability of SP in body fluids require fast quantitative methods for determining the 
relevant in-vivo level involved in the pathogenesis of certain diseases.  
In most study, SP was found approximately three times higher in saliva than in serum or plasma. Mean values for 
salivary SP levels ranged between 9.6 and 220 pg/ml in healthy normal controls
2-4
. Most of reported SP quantitative 
measurements relied on conventional ELISA methods, and surprisingly no data nowadays has been documented on 
immunochip-based analysis. 
Therefore, we herein present the first electrochemical SP detection method on microchip format. To overcome 
certain drawbacks encountered on microplate platform, we have designed a microfluidic analytical system with an 
implemented immunosensor array offering remarkable advantages with its easy fabrication, simple handling, low-
cost, and high sensitivity for rapid quantitative measurement of SP at physiological and pathological concentration 
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 ranges. Such assay improvement by simple miniaturization can be highly desirable in the establishment of a rapid 
and accurate SP-mediated disease diagnosis in emergency medicine.  
2. Experimental 
2.1. Fabrication of the microfluidic immunosensor-chip 
The Fig. 1 shows the developed microfluidic capillary immunosensor-chip. Microfluidic capillaries are therefore 
a must for miniaturized immunoassays because of the advantageous surface to volume ratio for enhanced signal 
enrichment in a very short time. 
The microdevice system is produced in wafers by photolithography. One wafer is consisted of 30 biochips (see 
Fig. 1a). Photo-patternable dry film resist (Vacrel 8100) is laminated in layers on a polyimide substrate
5
. The 
microchannel structures are incorporated by sequenced lamination and patterning the layers on the substrate. The 
meander shaped capillary ends in an electrochemical measurement cell with one auxiliary and one working platinum 
electrodes and one silver/silver chloride reference electrode. The liquids enter the immobilization cell via capillary 
forces and stop at the physical barrier, thus coating a well-defined area of the capillary (see Fig. 1b). 
 
                             
Fig. 1. (a) Section of a wafer; (b) Cross-section of the microfluidic immunosensor-chip: The capillary (immobilization cell) and the 
electrochemical measurement cell are shown. By dispensing a droplet on the inlet hole, the liquid enters the capillary and fills it by capillary 
forces (visualized by chemiluminescence). 
2.2. Measurement 
The Substance-P level in each sample is determined by a competitive immunoassay method. The assay 
preparation is significantly simplified and required very small volume. For each step in the preparation as well as for 
the measurement part only 5 !l of solution is needed. The liquid enters the system through the inlet port by 
capillary-forces and stops at the physical barrier (see Fig. 1b). 
As shown in the Fig. 2, the assay starts by the sequential immobilization of polyclonal primary and secondary 
capture antibodies on the activated resist material in the capillary, followed by a blocking step with a BSA solution 
in between both antibody immobilization procedure. Human serum, plasma and saliva samples from healthy donors 
(supplied by Sigma) were tested.  
With the incubation of the respective sample together with SP labelled with glucose oxidase (GOD) used as 
tracer, the contained SP antigen and the conjugate compete for binding specifically to the capture antibody (see Fig. 
2). A flow injection analysis like measurement carried out by incubating glucose solution. The GOD conjugated to 
SP converts glucose to gluconolactone and hydrogen peroxide. To accumulate the peroxide within the channel the 
flow is stopped for certain time intervals (1 and 2 min. respectively), followed by pumping the generated hydrogen 
peroxide to the measurement cell (at a flow rate of 15 !l/min), where it is oxidized on platinum working electrode at 
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+ 350 mV versus Ag/AgCl reference electrode. Additionally to the respective samples, a blank measurement was 
performed using a second chip in parallel, both connected to a two-channel potentiostat. The resulting current signal 
is inversely proportional to the specifically bound SP present in the sample. 
 
 
Fig. 2. Scheme of the performed electrochemical competitive immunoassay. 
3. Results 
The detectable amount of hydrogen peroxide accumulated during the stopped flow interval is in close relationship 
with the sensitivity of the immunoassay. A detection limit for SP was determined as 10 pg/ml (see Fig. 3a). A more 
pronounced current signal is visualized with longer incubation time (2 min. instead of 1 min.). In both cases the 
blank measurement shows the smallest signal of all samples. A typical standard curve of competitive assay is 
successfully obtained with the applied synthetic SP concentration in a range between 10 and 10.000 pg/ml. 
 
 
Fig. 3. (a) SP standard curve; Transient signals of stop-flow amperometric measurement of (b) human plasma, (c) serum and (d) saliva with 
increasing time intervals. While the flow is stopped, the peroxide is allowed to accumulate in the immobilization cell. After restarting the pump 
the peroxide is transported to the measurement cell where it is oxidized, producing the recorded current signal. 
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 The described chip-based assay delivers a fast and easy quantitative determination without exceeding the stability 
time of SP at physiological and pathological concentration ranges. The measurement can be accomplished within 2 
minutes and the total assay preparation is completed in 2 hours. 
The Fig. 3 shows the SP standard curve of competitive immunoassay and transient signals of stop-flow 
amperometric measurements of plasma, serum and saliva samples. We were able to quantified 110 pg/ml in plasma, 
120 pg/ml in serum and 200 pg/ml in saliva, as well. Whereas SP level was consistently similar both in plasma and 
serum, the measured level in human saliva was markedly two times higher. 
These results were nicely confirmed by using the commercial assay kit (Assay designs). Interestingly, all 
measured values were found to be in the physiological range
 
reported in healthy human volunteers
2-4
. The 
measurement of SP level in patients with painful disorders such as rheumatoid arthritis, osteoarthritis and 
fibromyalgia is in progress.  
4. Conclusion 
We have introduced a novel type of disposable immunosensor for the electrochemical detection and 
quantification of Substance-P in biological samples. Compared with commercially available ELISA methods, this 
on-chip sensing method requires smaller amount of sample (5 µl) to perform faster detection (within 2 minutes). 
Additionally, the microdevice offers promise for
 
rapid, simple, cost-effective analysis. A detection limit of 10 
pg/ml for SP is achieved with a working range of 10-10.000 pg/ml. The analytical performance of the developed 
biosensor was tested with human plasma, serum and saliva. The measured SP levels were in good reproducible 
correlation with the conventional immunoassay and reported values. 
Importantly, this type of chip-based biosensor could be suitable for
 
use in the mass production of miniaturized 
lab-on-a-chip devices
 
and open new opportunities for point of care diagnostics. 
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